Group 1 - The core point of the article is the investigation of Li Xin, former assistant general manager of China National Pharmaceutical Group, for serious violations of discipline and law [1][8]. - Li Xin was born in 1962, is a member of the Communist Party, holds a master's degree, and is a pharmacist [3]. - Li Xin has a long history in the pharmaceutical industry, having held various managerial positions in companies such as Beijing Yongzheng Pharmaceutical and Meikang Yongzheng before becoming assistant general manager at China National Pharmaceutical in December 2016 [5]. Group 2 - As of November 21, the stock price of China National Pharmaceutical was 10.87 yuan per share, with a total market capitalization of 16.3 billion yuan [6]. - There have been multiple reports of investigations involving individuals from China National Pharmaceutical, including Wang Zhiguang, a deputy general manager, who was also investigated earlier this year [8]. - The ongoing anti-corruption campaign in the pharmaceutical sector has intensified, with a joint notice issued by 14 ministries to address misconduct in the medical sales and service areas [8].

华润医药(03320.HK)发布2025年中期业绩，该集团取得收益人民币1318.67亿元(单位下同)，同比增加 2.54%;公司权益股东应占溢利20.77亿元，同比减少20.25%;每股盈利0.33元，拟派发中期股息每股0.072 元。 本文源自：金融界AI电报 ...

Core Points - The company has completed the registration capital change and the amendment of its Articles of Association following the approval of a share repurchase plan [2][3] - The registered capital of the company is now RMB 323,215.0988 million, reflecting an increase from the previous amount [2] - The company has obtained a new business license from the Jilin Provincial Market Supervision Administration [2] Summary by Sections - **Share Repurchase Plan**: The board of directors approved a share repurchase plan to buy back shares for the purpose of cancellation and reduction of registered capital [2] - **Business License and Registration Details**: The company has updated its business license, with the new registered capital and other relevant details [2] - **Amendments to Articles of Association**: The amendments include changes to the registered capital and total number of shares, while other provisions remain unchanged [2]